A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: Design, methodology and recruitment findings of COLEP

Leprosy Review

Volumn 75, Issue 4, 2004, Pages 376-388

  Moet, F J ^a   Oskam, L ^b   Faber, R ^a   Pahan, D ^c   Richardus, J H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROYAL TROPICAL INSTITUTE   (Netherlands)

^c Danish Bangladesh Leprosy Mission   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROSTATIC AGENT; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL TRANSMISSION; BANGLADESH; CHEMOPROPHYLAXIS; CHILD; CLINICAL STUDY; CLINICAL TRIAL; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTACT EXAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EARLY DIAGNOSIS; FOLLOW UP; GENETIC DISTANCE; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INCIDENCE; LEPROSY; LEPROSY CONTROL; MAJOR CLINICAL STUDY; METHODOLOGY; PATIENT CODING; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RISK FACTOR; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGE FACTORS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDIA; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; PILOT PROJECTS; PREVALENCE; REFERENCE VALUES; RIFAMPIN; RISK ASSESSMENT; SEX FACTORS; TREATMENT OUTCOME;

EID: 12444295408     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. World Health Organisation. Trends in leprosy detection. Wkly Epidemiol Rec, 1998; 73: 169-176.
2. World Health Organisation. Elimination of leprosy as a public health problem (update). Wkly Epidemiol Rec, 1998; 73: 308-312.
3. World Health Organisation. Press release. WHO/70, 1999.
4. Meima A, Richardus JH, Habbema JDF. Trends in leprosy case detection worldwide since 1985. Lepr Rev, 2004; 75: 19-33.
5. Kish L. Survey sampling. Wiley, New York, 1965.
6. Anon. Guidelines for the field management of leprosy. Danish Bangladesh Leprosy Mission, 2000.
7. Vijayakumaran P, Krishnamurthy P, Rao P, Declerq E. Chemoprophylaxis against leprosy: expectations and methodology of a trial. Lepr Rev, 2000; 71: S37-40; discussion S40-41.
8. Bührer-Sékula S, Smits HL, Gussenhoven GC et al. The ML Flow test: a simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol, 2003; 41: 1991-1995.
9. Bührer-Sékula S, Sarno EN, Oskam L et al. Use of ML dipstick as a tool to classify leprosy patients. Int J Lepr Other Mycobact Dis, 2000; 68: 456-463.
10. Meima A, Gupte MD, van Oortmarssen GJ, Habbema JD. SIMLEP: a simulation model for leprosy transmission and control. Int J Lepr Other Mycobact Dis, 1999; 67: 215-236.
11. Meima A, Smith WCS, van Oortmarssen GJ, Richardus JH, Habbema JD. The future incidence of leprosy: a scenario analysis. Bull World Health Org, 2004; 82: 373-380.
12. Moet FJ, Meima A, Oskam L, Richardus JH. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Unpublished data.
13. Fine PE, Sterne JA, Ponnighaus JM et al. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol, 1997; 146: 91-102.
14. van Beers SM, Hatta M, Klatser PR. Patient contact is the major determinant in incident leprosy: implications for future control. Int J Lepr Other Mycobact Dis, 1999; 67: 119-128.
15. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuberc Lung Dis, 1992; 73: 73-76.
16. Klatser PR, van Beers S, Madjid B et al. Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic. J Clin Microbiol, 1993; 31: 2947-2951.
17. van Beers SM, Izumi S, Madjid B et al. An epidemiological study of leprosy infection by serology and polymerase chain reaction. Int J Lepr Other Mycobact Dis, 1994; 62: 1-9.
18. van Beers SM, de Wit MY, Klatser PR. The epidemiology of Mycobacterium leprae: recent insight. FEMS Microbiol Lett, 1996; 136: 221-230.
19. Fine PE, Warndorff DK. Leprosy by the year - what is being eliminated?. Lepr Rev, 1997; 68: 201-202.
20. Meima A, Gupte MD, van Oortmarssen GJ, Habbema JD. Trends in leprosy case detection rates. Int J Lepr Other Mycobact Dis, 1997; 65: 305-319.
21. Anon. Transactions of the 15th International Leprosy Congress. Int J Lepr, 1999; 66: 531-609.
22. Visschedijk J, van de Broek J, Eggens H et al. Mycobacterium leprae-millennium resistant! Leprosy control on the threshold of a new era. Trop Med Int Health, 2000; 5: 388-399.
23. Smith CM, Smith WC. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy. J Infect, 2000; 41: 137-142.
24. Smith WC, Smith CM. Preventive treatment of leprosy: needs, opportunities, and feasibility. Int J Lepr Other Mycobact Dis, 1999; 67: S38-S44.
25. van Beers S, Hatta M, Klatser PR. Seroprevalence rates of antibodies to phenolic glycolipid-I among school children as an indicator of leprosy endemicity. Int J Lepr Other Mycobact Dis, 1999; 67: 243-249.
26. http://w3.whosea.org/leprosy/statusarch.htm.